Low-dose steroid dexamethasone to be used for treating COVID-19 in U.K.
Category: #health  By Nikita Chaurasia  Date: 2020-06-18
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

Low-dose steroid dexamethasone to be used for treating COVID-19 in U.K.

As reported by credible sources, in a recent development the U.K. government has permitted the state-funded NHS (National Health Service) to use an anti-inflammatory steroid called “dexamethasone” for treating coronavirus. The drug is apparently a part of the world’s biggest trial testing for coronavirus and it is known to reduce the chances of death by a third among patients on ventilators, while lowers the mortality by a fifth for those on oxygen.

The results come from Randomized Evaluation of Covid-19 therapy (Recovery) trial, which was conducted by Oxford University. The trial primarily focused on whether prevailing medications that are being used for other conditions could sought as an option for treating coronavirus.

For those uninitiated, the drug is already being used to lower inflammation in various conditions such as asthma, arthritis and other skin others. Dexamethasone helps to reduce the damage that occurs when the immunity system of the body goes into overdrive, which can be fatal.

Sources close to the matter reported that around 2,100 patients received 6mg dose of dexamethasone daily during the 10 day trial and their results were compared with a random sample of 4,300 patients with no additional treatment.

The UK government claims to have around 200,000 courses of dexamethasone in its stockpile. Prime Minister Boris Johnson was reported saying that the recent development is a noteworthy British scientific achievement and has taken the necessary steps to ensure surplus of supply, especially in the event of a second peak.

The World Health Organization (WHO) has seemingly welcomed the positive results of dexamethasone. However, WHO Executive Director of Health Emergencies Program Michael Ryan stated that powerful anti-inflammatory steroids such as dexamethasone should be used under medical supervision since the drug can assist the division and replication of the virus in the body.

In another news, Russia has reportedly initiated its first human trials of COVID-19 vaccine which was developed by Moscow-based Gamaleya research institute and is planned to be tested soon on two groups of 38 people each.

Source Credits –

https://www.bbc.com/news/health-53061281

https://www.bbc.com/news/health-53077879

https://weather.com/en-IN/india/coronavirus/news/2020-06-18-who-dexamethasone-results-cautious-use-covid-19

https://www.timesnownews.com/health/article/russia-begins-human-trials-of-its-covid-19-vaccine-epidemiologist-says-mass-vaccination-may-begin-this-fall/608114

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia     twitter

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More..

More News By Nikita Chaurasia

Ford takes on GM, Tesla by debuting its first hands-free driving system

Ford takes on GM, Tesla by debuting its first hands-free driving system

By Nikita Chaurasia

Ford Motor Company, the American multinational automaker, is reportedly planning on introducing a hands-free driving feature on its 2021 Mustang Models as well as 2021 F-150 pickup truck through a software update, by the end of the year. The automob...

Oculus Quest 2 update to include wireless PC streaming, 120Hz mode

Oculus Quest 2 update to include wireless PC streaming, 120Hz mode

By Nikita Chaurasia

Oculus, a subsidiary of Facebook, Inc., that develops and manufactures virtual reality headsets, has recently announced that Oculus Quest 2’s new v28 software update will include native wireless desktop PC streaming as well as 120 Hz refresh ra...

Levi’s boosts its sales outlook for first half of 2021 on vaccine hopes

Levi’s boosts its sales outlook for first half of 2021 on vaccine hopes

By Nikita Chaurasia

Levi Strauss & Co., an American clothing company, has reportedly raised its half-yearly revenue growth projection, counting on COVID-19 vaccine rollouts to reinstate the popularity of its physical stores. The denim-maker had previously beaten est...